Search Results for keywords:"DEA registration revocation"

The Drug Enforcement Administration (DEA) has revoked the DEA registration of Dr. Victor Augusto Silva from Tampa, Florida, due to his failure to comply with federal and state laws regarding controlled substances. The DEA found that Dr. Silva allowed an unauthorized individual to use his registration to issue prescriptions for controlled substances, which is against the law. As Dr. Silva did not adequately respond to the charges or demonstrate he can be trusted with prescribing controlled substances, the DEA determined his continued registration would not serve the public interest. As a result, his registration was revoked, and any pending applications for registration in Florida were denied.

The Drug Enforcement Administration (DEA) issued an Order to Show Cause to Dr. Matthew Okeke, who is based in Nevada. This order proposed revoking his DEA registration because he no longer has a valid state license or authority to handle controlled substances in Nevada. Dr. Okeke did not respond to the order, leading the DEA to proceed with final agency action to revoke his registration. The decision was signed by DEA Administrator Anne Milgram and is set to take effect on January 29, 2025.

The Drug Enforcement Administration (DEA) decided to revoke the registration of Neumann's Pharmacy, LLC, after finding that it repeatedly failed to ensure controlled substance prescriptions were issued for legitimate medical purposes and did not document resolutions of red flags like drug interactions and cash payments. The pharmacy also improperly filled prescriptions written by the owner’s father, which violates Louisiana law. Despite given opportunities, the pharmacy did not fully acknowledge its mistakes or demonstrate it corrected them, leading to concerns about its ability to responsibly handle controlled substances in the future. The agency emphasized the importance of deterrence and the severity of the misconduct, ultimately leading to revocation of the pharmacy's DEA registration.

The Drug Enforcement Administration (DEA) has decided to revoke Joely Keen's DEA registration because she is no longer authorized to handle controlled substances in Texas. Her licenses to practice as an advanced practice registered nurse (APRN) and registered nurse in Texas have been revoked, and she lacks a necessary prescriptive authority agreement with a supervising physician. Without these, she cannot legally prescribe or dispense controlled substances, resulting in the loss of her DEA registration. The order becomes effective on April 28, 2025.

The Drug Enforcement Administration (DEA) issued an Order to Show Cause to Laura M. Bellew, a nurse practitioner from New Mexico, proposing to revoke her DEA registration because she no longer has the authority to handle controlled substances in New Mexico. This is because her nursing licenses were suspended by the New Mexico State Board of Nursing in January 2023. Bellew did not request a hearing to contest the charges, effectively admitting the DEA's allegations. As a result, the DEA decided to revoke her registration and deny any pending applications related to controlled substances in New Mexico.

The Drug Enforcement Administration (DEA) issued an order to revoke the registration of Dr. Ajumobi Agu in Nevada due to violations of the Controlled Substances Act (CSA). Dr. Agu continued prescribing controlled substances even after his state medical and controlled substances licenses were suspended. The DEA concluded that his actions are inconsistent with the public interest and deemed him untrustworthy to handle such substances. As such, Dr. Agu will be unable to apply to renew or modify his DEA registration, effective May 16, 2025.

The Drug Enforcement Administration (DEA) has revoked the DEA registration of Dr. Milad I. Shaker due to his lack of authority to handle controlled substances in Pennsylvania. This decision followed the suspension of his medical license in Pennsylvania after he was found noncompliant with probation terms and was convicted of unlawfully distributing a controlled substance. Dr. Shaker did not request a hearing or submit a corrective action plan, leading to the automatic waiver of these rights. As a result, his registration has been revoked, and any pending applications to renew or modify this registration have been denied.

The Drug Enforcement Administration (DEA) issued an order to revoke Maria Dewitt's registration to handle controlled substances because she lacks the necessary authorization in Texas. Dewitt did not have a required prescriptive authority delegation agreement with a physician, which is essential for an advanced practice registered nurse in Texas to manage controlled substances. The administrative law judge upheld this decision, noting that without state authorization, Dewitt could not maintain her DEA registration. Consequently, her registration was revoked, and any further applications for registration in Texas were denied.

The Drug Enforcement Administration (DEA) revoked the registration of Hazem Barmada, M.D., allowing him to handle controlled substances in Mississippi because he no longer has a valid medical license in the state. The Mississippi State Board of Medical Licensure had accepted his voluntary surrender of the license in 2021, making him ineligible to practice medicine and handle controlled substances there. As holding a valid state license is necessary for DEA registration, Dr. Barmada’s registration was revoked, and any pending applications related to it were denied. This decision will take effect on April 21, 2025.

The Drug Enforcement Administration (DEA) has revoked the DEA registration of Xubex Community Pharmacy in Casselberry, Florida. This decision was made because the pharmacy dispensed controlled substances, specifically Schedule II drugs like oxycodone and hydromorphone, without prescriptions. The DEA considered these actions a threat to public health and safety, demonstrating that the pharmacy cannot be trusted to comply with legal requirements. Furthermore, the pharmacy did not request a hearing to dispute these conclusions, leading to the default revocation of its registration.